Inclusion Criteria Patient has definitive histologically or cytologically confirmed metastatic adenocarcinoma of the pancreas. The definitive diagnosis.
I Can’t Believe It’s Not JEOPARDY!
Uterine Cancers A. Alobaid, MBBS, FRCS(C), FACOG Consultant, Gynecologic Oncology Assistant professor, KSU Medical Director, Women’s Specialized Hospital.
Herceptin ® adjuvant therapy: “a triumphal narrative of translational research” Brian Leyland-Jones McGill University Department of Oncology Montreal,
Discussion abstracts 4006-4009
Is targeted therapy ready for the adjuvant setting ? Emile E. Voest Department of Medical Oncology
Harold J. Burstein, MD, PhD Dana-Farber Cancer Institute Harvard Medical School Boston, MA
Discussion abstracts 4006-4009 Alberto Sobrero MD Ospedale San Martino Genoa, Italy.
Uterine Cancers
Why did the antibodies fail in adjuvant treatment? Heinz-Josef Lenz Associate Director, Clinical Research Kathryn Balakrishnan Chair for Cancer Research.
Inclusion Criteria
Eyob Cancer Discovery 2013
